23.11.2021 • NewsVersalis

Tatneft Licenses Rubber Technology from Versalis

Russian oil and rubber company Tatneft has signed a license and engineering contract with Italy’s Versalis for two new rubber plants in Togliatti. The value of the contract was not disclosed.

Under the agreement, Tatneft will build plants producing 70,000 t/y nitrile butadiene rubber (NBR) and 30,000 t/y carboxylate styrene butadiene rubber latexes (XSBR) using Versalis technology. Tatneft did not reveal when the plants would go into operation.

NBR rubbers have high resistance to aliphatic hydrocarbons, gasoline and lubricants, as well as good flexibility at low temperatures, making them suitable for use in various industrial fields. XSBR latexes are used in the production of adhesives, paper and cardboard coverings and mat bases, among other products.

Tatneft said the project is the next step in its plans for a petrochemical cluster at the site. The group bought the Togliatti rubber assets from Sibur in November 2019, saying at the time that it intended to develop them further in line with its gas and petrochemical strategy.

Sibur made the divestment as it wanted to “concentrate efforts on establishing and developing global-scale production of basic polymers, high-potential medium-tonnage products and premium special chemicals.”

Author: Elaine Burridge, Freelance Journalist

Russia’sTatneft has signed a license and engineering contract with Italy’s...
Russia’sTatneft has signed a license and engineering contract with Italy’s Versalis for two rubber projects in Togliatti. Tatneft will build plants producing 70,000 t/y nitrile butadiene rubber (NBR) and 30,000 t/y carboxylate styrene butadiene rubber latexes (XSBR). (c) eni

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read